Get started
Author

Purvi Parikh

Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection
2022 · Bruce K. Patterson, Edgar B. Francisco, et al. · Frontiers in Immunology · 281
Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning
2021 · Bruce K Patterson, Jose Guevara-Coto, et al. · Frontiers in Immunology · 188
PDF
Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines
2021 · Kevin R. Murphy, Niraj C. Patel, et al. · Annals of Allergy Asthma & Immunology · 26
PDF
Case series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequelae of COVID (PASC)
2023 · Bruce K. Patterson, Ram Yogendra, et al. · Frontiers in Medicine · 20
PDF
COVID-19 pandemic impact on telehealth use and perceptions for atopic and respiratory disease: Survey results
2022 · Don A. Bukstein, Jacqueline Eghrari-Sabet, et al. · Allergy and Asthma Proceedings · 11
The economic implications of penicillin allergy
2020 · Purvi Parikh, Niraj C. Patel, et al. · Annals of Allergy Asthma & Immunology · 4
Targeting the Monocytic-Endothelial-Platelet Axis with Maraviroc and Pravastatin as a Therapeutic Option to Treat Long COVID/ Post-Acute Sequelae of COVID (PASC)
2022 · Bruce Patterson, Ram Yogendra, et al. · Research Square · 3
PDF
Cytokine Hub Classification of PASC, ME-CFS and other PASC-like Conditions
2022 · Bruce K. Patterson, Jose Guevara-Coto, et al. · Research Square · 2
PDF
Disseminated HSV-2 presenting with relapsing encephalomyelitis
2016 · Clotilde Hainline, Dominique Rosales, et al. · Neurology Clinical Practice · 2
PDF
Highlighting the variability in presenting symptoms of chronic granulomatous disease
2016 · Claire Bottomley, Patricia Davenport, et al. · Annals of Allergy Asthma & Immunology · 1
Correction: Persistence of SARS CoV-2 S1 protein in CD16+ monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection
2026 · Bruce K. Patterson, Edgar B. Francisco, et al. · Frontiers in Immunology
PDF
Corrigendum: Case Series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequalae of COVID (PASC)
2024 · Bruce K. Patterson, Ram Yogendra, et al. · Frontiers in Medicine
Works count: 12
Citation count: 538
H-index: 5
I10-index: 5
Year
Topic
Type